×
About 180 results

ALLMedicine™ Amenorrhea Center - Drugs

Clomiphene citrate - clomiphene citrate tablet-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d544453-f6d4-45a4-9ece-2f705b32011f

Mar 4th, 2018 - Clomiphene citrate tablets USP is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate tablets USP therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS: Ovarian Hyperstim...

Hydroxyprogesterone caproate - hydroxyprogesterone caproate injection-McGuff Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a17836c6-c8d5-4408-a593-6b0de828571a

Aug 30th, 2015 - Hydroxyprogesterone Caproate Injection USP is indicated in non-pregnant women: for the treatment of advanced adenocarcinoma of the uterine corpus (Stage III or IV); in the management of amenorrhea (primary and secondary) and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer; as a test for endogenous estrogen pro...

Progesterone - progesterone capsule-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f12f28-b676-2b60-e054-00144ff88e88

Jan 24th, 2017 - Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

Progesterone - progesterone capsule-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=849e9f62-7414-3c22-9cb1-934f953400fc

Aug 21st, 2017 - Progesterone Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

Bromocriptine mesylate - bromocriptine mesylate tablet-KAISER FOUNDATION HOSPITALS
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb51d2be-d9ff-46b8-8bc1-d97d1c615202

Feb 20th, 2017 - Bromocriptine mesylate tablets are indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. Bromocriptine mesylate tablets treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. Red...

Prometrium - progesterone capsule-AbbVie Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0224b5a6-25a3-44c9-b94f-90e2e064c164

Apr 25th, 2017 - PROMETRIUM Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

Bromocriptine mesylate - bromocriptine mesylate capsule-Avera McKennan Hospital
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b72e4ab3-8bd4-4e28-b8d4-6924c154b01c

Mar 22nd, 2017 - Bromocriptine mesylate tablets and capsules are indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. Bromocriptine treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. Reducti...

Medroxyprogesterone acetate - medroxyprogesterone acetate tablet-NuCare Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43a33a55-a888-6d06-e054-00144ff8d46c

Dec 13th, 2016 - Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0....

Bromocriptine mesylate - bromocriptine mesylate tablet-Carilion Materials Management
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b89ff149-e33a-46cb-9649-64583e78a7ee

Jul 5th, 2017 - Bromocriptine mesylate tablets are indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. Bromocriptine mesylate tablets treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. Red...

Hydroxyprogesterone caproate - hydroxyprogesterone caproate injection-ANI Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdfa01cc-6315-44d4-ba79-3705fafe7ebe

Nov 16th, 2017 - Hydroxyprogesterone Caproate Injection USP is indicated in non-pregnant women: for the treatment of advanced adenocarcinoma of the uterine corpus (Stage III or IV); in the management of amenorrhea (primary and secondary) and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer; as a test for endogenous estrogen pro...

Medroxyprogesterone acetate - medroxyprogesterone acetate tablet-Avera McKennan Hospital
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b67cd36-7199-42ff-a8a7-cecc81679676

Mar 16th, 2017 - Medroxyprogesterone acetate tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 ...

Progesterone - progesterone capsule-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29a1089b-8c60-63a4-e054-00144ff88e88

Oct 16th, 2017 - Progesterone Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

Progesterone - progesterone capsule-Bionpharma Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3acad9b0-7ec6-4d5e-9852-32ffadbbed6d

Mar 10th, 2018 - Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

Clomiphene citrate - clomiphene citrate tablet-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53eff40f-37b1-47b1-a9b8-c22360855f18

Apr 23rd, 2018 - Clomiphene citrate tablets USP is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate tablets USP therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS: Ovarian Hyperstim...

Clomiphene citrate - clomiphene citrate tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b10aaa1-fcf8-42c5-9b5a-1ac6bc417bdf

May 17th, 2018 - Clomiphene citrate tablets USP is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate tablets USP therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS: Ovarian Hyperstim...

Crinone - progesterone gel-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7def92fe-d521-41c0-b419-48e028f59f15

Nov 29th, 2017 - Crinone 8% is indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology ("ART") treatment for infertile women with progesterone deficiency. Crinone 4% is indicated for the treatment of secondary amenorrhea. Crinone 8% is indicated for use in women who have failed to respond to treatment with Crinone 4%.

Progesterone - progesterone injection-West-Ward Pharmaceuticals Corp
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83cfc12e-75d1-4284-bcc3-beadcbd27171

Dec 13th, 2018 - This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.

Medroxyprogesterone acetate - medroxyprogesterone acetate tablet-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1d5975a-e0e5-444d-bab0-3904c3f377c9

Dec 16th, 2018 - Medroxyprogesterone acetate tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 ...

Norethindrone acetate - norethindrone tablet-AvKARE, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=827c7ef1-a8b7-d0c4-b062-c5154b331a35

Jun 17th, 2018 - Norethindrone acetate tablets, USP is indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer. Norethindrone acetate tablets, USP are not intended, recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for en...

Crinone - progesterone gel-Allergan, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75e97aa1-daa4-45f9-b2e2-1a371302914e

Jan 15th, 2019 - Assisted Reproductive Technology Crinone 8% is indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology ("ART") treatment for infertile women with progesterone deficiency. Secondary Amenorrhea Crinone 4% is indicated for the treatment of secondary amenorrhea. Crinone 8% is indicated for use in women who have failed to respond to treatment with Cri...